Purchase Order 75N95C24P00056
- Not listed
- The Department of Health and Human Services National Institutes of Health National Institute of Child Health and Human Development (NICHD) awarded a Firm Fixed Price purchase order to Synthego Corporation, a self-certified small disadvantaged business, for the provision of custom knockin cell clones. The contract has a potential value of $11,450.00 and a completion date of September 9, 2024. Synthego Corporation is a leading provider of genome engineering solutions and has been awarded over 30...
- This is a $12,775 firm fixed-price purchase order awarded by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Synthego Corporation, a small disadvantaged business manufacturer of gene editing products. The contract is for Synthego to provide knock-in cell line generation services to support cell biology experiments for Dr. Martina. While this contract is not set aside, Synthego has previously been awarded over 30 prime federal...
- This is a $33,750 firm-fixed price purchase order contract awarded by the National Institute of Environmental Health Sciences (NIEHS), a civilian federal agency, to Synthego Corporation, a self-certified small disadvantaged business manufacturer of gene editing products. The contract is for the provision of "SYTHEGO - KNOCK-IN AND KNOCK-OUT CELL CLONES" services to support biomedical research efforts across various government agencies. This is not a set-aside contract. Synthego has...
- This is a $25,150.00 firm fixed price purchase order contract awarded by the National Institute of Child Health and Human Development (NICHD), part of the Department of Health and Human Services, to Synthego Corporation, a small disadvantaged business manufacturer of gene editing products. The contract is for CRISPR genome engineering and related services to support biomedical research efforts across multiple NIH institutes. Synthego specializes in custom cell line development, gene...
- This is a definitive contract awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Center for Advancing Translational Sciences to Synthego Corporation, a small disadvantaged business, for IPSC engineering services. The firm-fixed-price contract, valued at $1,939,814.20, does not have a set-aside designation. Through this contract, Synthego will provide the NIH with various gene editing products and services, including custom cell clones,...
- The Department of Health and Human Services, National Institutes of Health, National Institute of Allergy and Infectious Diseases awarded a firm fixed-price purchase order contract to Synthego Corporation, a self-certified small disadvantaged business, for $188,840.00 to provide gene editing services. The contract is for the delivery of GMP-like CRISPRevolution modified single guide RNA (mod-sgRNA) sequences to support ongoing research within the LCIM program. The agency determined Synthego to...
- This federal contract award, valued at $22,825.00, was issued by the National Center for Advancing Translational Sciences (NCATS), a civilian agency within the National Institutes of Health (NIH). The contract was awarded to Synthego Corporation, a self-certified small disadvantaged business and manufacturer of gene editing products based in Redwood City, California. The contract is for the delivery of KNOCKIN-SMALL, CELL CLONE, IPSC, SYNTHEGO SUPPLIED services, which likely support NCATS'...
- This is a $146,665.75 firm fixed-price purchase order contract awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute on Drug Abuse to Synthego Corporation, a self-certified small disadvantaged business and manufacturer of goods. The contract was not set aside. Synthego, headquartered in Redwood City, California, is providing genome engineering solutions, including cell line engineering, CRISPR libraries, and other biological...
- This federal contract was awarded by the Department of Health and Human Services (HHS), National Institutes of Health (NIH), National Center for Advancing Translational Sciences to Synthego Corporation, a self-certified small disadvantaged business, for high-throughput screening to identify modulators of the expression of human HIF1 and HIF2. The firm fixed price purchase order, valued at $22,650.00, will support genetic research at Synthego's facilities in Redwood City, California through...
- This is a $60,132.50 firm-fixed-price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency within the National Institutes of Health (NIH), to Synthego Corporation, a self-certified small disadvantaged business and manufacturer of gene editing products. The contract is for the provision of a Whole Human Genome Arrayed CRISPR Screening Library to support NCATS' translational science research efforts. This award is not associated with a...
The Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences awarded a Firm Fixed Price Purchase Order to Synthego Corporation, a self-certified small disadvantaged business, for the delivery of KNOCKIN-SMALL, CELL CLONE, IMMORTALIZED with a potential value of $12,950.00. This order is part of Synthego's extensive portfolio of federal contracts to provide gene editing products, cell line engineering, and research support services to various NIH institutes such as the National Institute on Drug Abuse, National Institute of Allergy and Infectious Diseases, and National Cancer Institute. Synthego, a leading provider of genome engineering solutions, has been awarded over 30 prime federal contracts to deliver a wide range of offerings including custom cell clones, engineered knock-in and knockout cell pools, and CRISPR stem cell engineering. This particular contract has a completion date of July 20, 2024 and was awarded on May 21, 2024 without the use of a set-aside.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.0k | 5/21/24 |